Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03045328
Title Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Steven E. Coutre
Indications

chronic lymphocytic leukemia

Therapies

Ibrutinib + Venetoclax

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.